Article
A review of the use of tumour DNA methylation for breast cancer subtyping and prediction of outcomes
2 Jul 2025
Abstract excerpt
DNA methylation in breast tumours has been extensively studied and has provided valuable insights into the clinical heterogeneity of breast cancer. In this review, we summarise the current literature that has used DNA methylation markers to subtype breast cancer and predict progression and survival. Widespread methylation differences have been observed across breast cancer subtypes at both the candidate genes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
